Medsien has raised $4.0M in total across 1 funding round.
Medsien's investors include Merus Capital, Ulu Ventures.
Medsien is an AI-powered technology platform specializing in remote care management for chronic conditions, automating workflows like patient eligibility, enrollment, monitoring, billing, and compliance. Founded in 2018 and headquartered in San Francisco, it serves accountable care organizations, independent practices, FQHCs, community health centers, hospitals, and health systems by handling programs such as CCM (Chronic Care Management), RPM (Remote Patient Monitoring), RTM (Remote Therapeutic Monitoring), PCM (Principal Care Management), TCM (Transitional Care Management), and AWV (Annual Wellness Visits).[1][2][3] The platform solves key pain points in healthcare—improving patient outcomes for over 150 million U.S. adults with chronic conditions (where only 20% currently access remote care), boosting efficiencies, reducing costs, and enhancing engagement through scalable AI automation and hybrid human support, with rapid deployment in as little as 5 days.[1][2][5] Medsien has raised under $5M in funding and is trusted by hundreds of organizations, demonstrating steady growth in the health tech space.[2][3]
Medsien was founded in 2018 in San Francisco by serial entrepreneurs who identified a critical gap in healthcare technology, an industry ripe for innovation despite its massive needs.[3][5] Unlike typical serial ventures in flashy areas like autonomous vehicles or space tech, the founders targeted healthcare to deliver real, life-changing impact amid the chronic disease epidemic affecting over 60% of U.S. adults—more than 150 million people—with limited remote care access.[5] Early traction came from launching specialized programs, including RPM in 2021 and the first-on-market Pain Management RTM solution in 2022, aligning with CMS reimbursement expansions to capitalize on emerging regulatory tailwinds.[3] This bootstrapped evolution, with under $5M in total funding across one round, positioned Medsien as a nimble innovator automating compliance-heavy CCM processes for healthcare providers.[3]
Medsien stands out in remote care management through its blend of cutting-edge AI and human empathy, delivering the "fastest platform on the market" with launches in 5 days and seamless EHR integrations.[1][2]
Medsien rides the explosive growth of digital health and remote monitoring, fueled by post-pandemic telehealth adoption, CMS reimbursements for RPM/RTM since 2021-2022, and AI's rise in automating healthcare's administrative burdens.[1][3] Timing is ideal amid chronic disease prevalence (150M+ U.S. adults) and provider shortages, where market forces like value-based care and cost pressures favor scalable platforms that bridge only 20% remote care access gaps.[2][5] By integrating AI with empathetic staffing and EHRs, Medsien influences the ecosystem as a "technology company at heart," enabling practices to evolve "from routine to remarkable," expanding reach for vulnerable patients, and setting benchmarks for compliant, efficient hybrid models in a $100B+ remote care market.[1][2]
Medsien is primed for acceleration through deeper AI enhancements, like expanded generative tools for predictive analytics and more RPM device integrations, amid surging demand for chronic care amid aging populations and AI-healthcare convergence.[1][4] Trends like FHIR-standardized data interoperability and further CMS expansions will amplify its momentum, potentially driving acquisition interest from larger health systems or EHR giants. Its influence could evolve from niche innovator to category leader, humanizing AI in care to boost outcomes at scale—echoing its founding mission to impact lives profoundly in an industry transforming from reactive to proactive.[5]
Medsien has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2022 | $4.0M Seed | Merus Capital, Ulu Ventures |
